These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19782016)

  • 21. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia.
    Rondags SM; de Wit M; Snoek FJ
    Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors limiting glycaemic control in insulin-treated type 2 diabetes].
    Ferencz V; Domján B; Gerő L; Tänczer T; Tabák GÁ
    Orv Hetil; 2015 Sep; 156(36):1443-50. PubMed ID: 26320598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials.
    Kautzky-Willer A; Kosi L; Lin J; Mihaljevic R
    Diabetes Obes Metab; 2015 Jun; 17(6):533-540. PubMed ID: 25678212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin therapy for type 2 diabetes.
    Swinnen SG; Hoekstra JB; DeVries JH
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S253-9. PubMed ID: 19875560
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
    Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
    JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.
    UK Hypoglycaemia Study Group
    Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.
    Franek E; Haluzík M; Canecki Varžić S; Sargin M; Macura S; Zacho J; Christiansen JS
    Diabet Med; 2016 Apr; 33(4):497-505. PubMed ID: 26435365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3).
    Bolli GB; Riddle MC; Bergenstal RM; Ziemen M; Sestakauskas K; Goyeau H; Home PD;
    Diabetes Obes Metab; 2015 Apr; 17(4):386-94. PubMed ID: 25641260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world patient-reported rates of non-severe hypoglycaemic events in Germany.
    Kulzer B; Seitz L; Kern W
    Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):167-72. PubMed ID: 24643694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
    Kostev K; Dippel FW; Rathmann W
    Prim Care Diabetes; 2014 Jul; 8(2):127-31. PubMed ID: 24183472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of cardiovascular and metabolic outcomes in people with type 2 diabetes on insulin versus non-insulin glucose-lowering therapies (GLTs): A systematic review and meta-analysis of clinical trials.
    Anyanwagu U; Mamza J; Donnelly R; Idris I
    Diabetes Res Clin Pract; 2016 Nov; 121():69-85. PubMed ID: 27662041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies to prevent hypoglycaemia during insulin therapy in Type 2 diabetes.
    Yki-Järvinen H
    Diabetes Nutr Metab; 2002 Dec; 15(6):411-6. PubMed ID: 12678459
    [No Abstract]   [Full Text] [Related]  

  • 34. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypoglycaemia in elderly patients with type 2 diabetes and coexistence of cardiovascular history.
    Piątkiewicz P; Buraczewska-Leszczyńska B; Kuczerowski R; Bernat-Karpińska M; Rabijewski M; Kowrach M
    Kardiol Pol; 2016; 74(8):779-785. PubMed ID: 27040016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management.
    International Hypoglycaemia Study Group
    Lancet Diabetes Endocrinol; 2019 May; 7(5):385-396. PubMed ID: 30926258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).
    Vora J; Cohen N; Evans M; Hockey A; Speight J; Whately-Smith C
    Diabetes Obes Metab; 2015 Dec; 17(12):1133-41. PubMed ID: 26085028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.
    Sämann A; Mühlhauser I; Bender R; Kloos Ch; Müller UA
    Diabetologia; 2005 Oct; 48(10):1965-70. PubMed ID: 16132954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treat-to-target trials: uses, interpretation and review of concepts.
    Garber AJ
    Diabetes Obes Metab; 2014 Mar; 16(3):193-205. PubMed ID: 23668598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long acting insulin analogues: results of clinical studies with insulin glargine].
    Fritsche A
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S101-5; discussion S124-6. PubMed ID: 18686217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.